Multi-b-value DWI to evaluate the synergistic antiproliferation and anti-heterogeneity effects of bufalin plus sorafenib in an orthotopic HCC model.

Ran GuoFang LuJiang LinCaixia FuMengxiao LiuShuohui Yang

Published in: European radiology experimental (2024)

• Bufalin plus sorafenib combination may increase the effectiveness of HCC therapy. • Multi-b-value DWI depicted HCC proliferation, angiogenesis, and spatial heterogeneity. • Multi-b-value DWI may be a noninvasive method to assess HCC therapeutic efficacy.

Keyphrases

diffusion weighted imaging
diffusion weighted
single cell
randomized controlled trial
systematic review
signaling pathway
magnetic resonance imaging
computed tomography
contrast enhanced
vascular endothelial growth factor
cancer therapy
magnetic resonance